Received Feb 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 5g23d | SC / LL |
This vaccine was administered subcutaneously instead of Intramuscular. There have been no adverse reactions from this administration. Provided was consulted and the necessary follow up actions were taken.
None
None
None
None
NA